Trial Profile
A follow-up study exploring number of cycles for weekly treatment with Paclical in patients with metastatic breast cancer, previously treated in study OAS-11PAC-W
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 20 Apr 2023
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Vivesto
- 02 Sep 2014 New trial record